GGGGCC (G 4 C 2 ) repeat expansion in C9ORF72 is the most common genetic cause of ALS and FTD. An important issue is how repeat RNAs and their translation products, various dipeptide repeat (DPR) proteins, cause neurodegeneration. Drosophila has been widely used to model G 4 C 2 repeat RNA and DPR protein toxicity. Overexpression of disease molecules in flies has revealed important molecular insights. These have been validated and further explored in human neurons differentiated from induced pluripotent stem cells (iPSCs), a disease-relevant model in which expanded G 4 C 2 repeats are expressed in their native molecular context. Approaches that combine the genetic power of Drosophila and the disease relevance of iPSC-derived patient neurons will continue to unravel the underlying pathogenic mechanisms and help identify potential therapeutic targets in C9ORF72-ALS/FTD.
C9ORF72 Repeat Expansion in ALS and FTD
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a fatal, progressive, neurodegenerative disorder caused by degeneration of upper and lower motor neurons in the brain and spinal cord [1] . Although ALS has long been considered a motor neuron disease, some ALS patients have symptoms of frontotemporal dementia (FTD). The two disorders share many pathological and genetic features as well as several dysfunctional molecular pathways downstream of many common disease-causing genetic mutations [2] . FTD, the second most common form of presenile dementia after Alzheimer's disease, is accompanied by focal degeneration of the prefrontal and/or temporal cortex and changes in behavior, language, and executive functions [3] . FTD is a clinically heterogeneous disorder that includes behavioral variant FTD, semantic dementia, progressive nonfluent aphasia, FTD with motor neuron disease, and other conditions [3] .
The most common genetic cause of both ALS and FTD is a GGGGCC (G 4 C 2 ) repeat expansion in the noncoding region of a previously uncharacterized gene, C9ORF72 [4, 5] . How a single genetic mutation such as C9ORF72 repeat expansion causes distinct yet overlapping diseases is unclear. It is possible that different genetic modifiers and environmental influences also play a role. In 2011, the identification of this unusual ALS/FTD-causing mutation galvanized the field, leading to breathtaking progress in recent years. Much of this progress reflects the intellectual challenge posed by the multifaceted nature of the underlying pathogenic mechanisms. First, C9ORF72 expression is reduced by G 4 C 2 repeat expansion, suggesting haploinsufficiency as a potential disease-causing mechanism. In cells and tissues of C9ORF72 patients, expression of C9ORF72 transcript variant 2 and total full-length C9ORF72 is reduced by expanded repeats in the promoter region [4, [6] [7] [8] [9] [10] [11] . However, C9orf72 knockout mice have no detectable neurodegeneration [12] [13] [14] [15] [16] [17] [18] , arguing against haploinsufficiency as a primary mechanism of disease, although partial loss of C9orf72 function in microglia may influence disease progression [16] .
Highlights
The toxicity of expanded G 4 C 2 repeats in Drosophila models is influenced by their molecular context. DPR proteins, but not RNA foci, are major toxic molecules in Drosophila models of G 4 C 2 repeat expansion.
Nucleocytoplasmic transport defects are found in both Drosophila models of G 4 C 2 repeat expansion and neurons derived from C9ORF72 iPSCs.
Multiple interconnected molecular pathways are dysregulated in C9ORF72-ALS/FTD, such as autophagy, stress granule dynamics, oxidative stress DNA damage, nucleolar stress, and neuronal excitability.
Experimental approaches that combine the genetic power of Drosophila and the disease relevance of iPSCderived patient neurons are excellent strategies to help uncover pathogenic mechanisms in C9ORF72-ALS/FTD.
